Cite
MLA Citation
Laura S. Graham et al.. “Targeting backdoor androgen synthesis through AKR1C3 inhibition: A presurgical hormonal ablative neoadjuvant trial in high‐risk localized prostate cancer.” Prostate, vol. 81, no. 7, 2021, pp. 418–426. http://access.bl.uk/ark:/81055/vdc_100127440990.0x000046